No Data
No Data
No Data
Telix Pharmaceuticals Price Target Raised 35% to A$20.70/Share by Jefferies
Telix Pharmaceuticals Price Target Raised 35% to A$20.70/Share by Jefferies
AU Weekly Wrap | May Unemplyment Rate Falls; Telix Pharmaceuticals Shares Sink on Unexpected Nasdaq News
Check out what happened in this week's AU stock market as well as the key economic data for next week.
Why Is the Telix Pharmaceuticals Share Price Frozen Today?
Up 63% so far in 2024, the Telix Pharmaceuticals Ltd (ASX: TLX) share price isn't going anywhere today.
Telix Pharmaceuticals Launches $200 Million IPO in US
Telix Pharmaceuticals (TLX) said Wednesday it has launched an initial public offering in the US of 17 million American depositary shares, each representing one ordinary share, for expected gross proce
Australian biotechnology company Telix Pharmaceuticals (TLX.US) plans to IPO with a price of $11.87, raising $202 million.
Telix Pharmaceuticals plans to issue 17 million American Depositary Shares at a price of $11.87 per share (converted from its latest closing price on the Australian Securities Exchange) to raise $202 million.
Telix, Radiopharmaceuticals Maker, Sets Terms for $232M US IPO
No Data